Avadel Pharmaceuticals

NASDAQ: AVDL · Real-Time Price · USD
13.69
0.19 (1.41%)
At close: Aug 15, 2025, 3:59 PM
13.69
0.04%
After-hours: Aug 15, 2025, 04:10 PM EDT

Avadel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-48.83M -160.28M -137.46M -77.33M
Depreciation & Amortization
2.68M 1.77M 1.49M 815K
Stock-Based Compensation
20.39M 15.81M 7.01M 8.87M
Other Working Capital
14.99M 15.21M 27.64M -537K
Other Non-Cash Items
-828K 17.19M 8.09M 2.3M
Deferred Income Tax
n/a n/a 26.02M -15.67M
Change in Working Capital
-20.32M -3M 24.54M 3.69M
Operating Cash Flow
-46.91M -128.51M -70.3M -77.31M
Capital Expenditures
n/a n/a -716K -26K
Cash Acquisitions
n/a n/a -80.41M 16.5M
Purchase of Investments
-276M -237.23M -3.41M -61.77M
Sales Maturities Of Investments
327.78M 187.14M 83.83M 102.22M
Other Investing Acitivies
n/a n/a 80.41M 16.5M
Investing Cash Flow
51.78M -50.09M 79.7M 56.93M
Debt Repayment
n/a -38.66M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
6.72M 27.94M -10.78M 263K
Financial Cash Flow
15.97M 135.34M 14.54M 263K
Net Cash Flow
20.2M -42.81M 23.27M -21.01M
Free Cash Flow
-46.91M -128.51M -71.02M -77.34M